{"transactions":[{"id":1161480,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-05-02T20:09:44.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":5750,"derivative":{"exercise_price":60.03,"expiration_date":"2035-05-01","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-011776","document":"form4-05022025_080541.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588925011776/form4-05022025_080541.xml","form_type":"4"}},{"id":1161479,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-02T20:09:44.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":4165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) May 1, 2026 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":24937,"source":{"system":"sec-edgar","filing":"0001415889-25-011776","document":"form4-05022025_080541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588925011776/form4-05022025_080541.xml","form_type":"4"}},{"id":1533936,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-04-29T22:08:11.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":8804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":8804,"derivative":{"exercise_price":38.46,"expiration_date":"2034-04-25","underlying":"Common Stock","underlying_shares":8804},"source":{"system":"sec-edgar","filing":"0001415889-24-011701","document":"form4-04292024_100402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924011701/form4-04292024_100402.xml","form_type":"4"}},{"id":1533935,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-29T22:08:11.000Z","date":"2024-04-25","kind":"grant","planned":false,"acquired":true,"shares":6501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) April 25, 2025 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":20772,"source":{"system":"sec-edgar","filing":"0001415889-24-011701","document":"form4-04292024_100402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588924011701/form4-04292024_100402.xml","form_type":"4"}},{"id":1899770,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-05-09T22:24:04.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":11371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":11371,"derivative":{"exercise_price":31,"exercise_date":"2024-05-05","expiration_date":"2033-05-05","underlying":"Common Stock","underlying_shares":11371},"source":{"system":"sec-edgar","filing":"0001415889-23-007693","document":"form4-05092023_100556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588923007693/form4-05092023_100556.xml","form_type":"4"}},{"id":1899769,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-09T22:24:04.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":8065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":14271,"source":{"system":"sec-edgar","filing":"0001415889-23-007693","document":"form4-05092023_100556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588923007693/form4-05092023_100556.xml","form_type":"4"}},{"id":2279552,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":43106,"kind":"person","name":"Miyashita Akiko Moni","position":1,"cik":"0001607742","reported_name":"Miyashita Akiko Moni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-07T00:07:19.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":6206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 5, 2023 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":6206,"source":{"system":"sec-edgar","filing":"0001179110-22-002911","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911022002911/edgar.xml","form_type":"4"}}]}